ADIPOQ and type 2 diabetes mellitus: These data corroborate with our findings, where supplementation with Eriomin increased serum adiponectin levels by 18% and reduced the concentration of C‐peptide by 5%, an important marker of beta cell function that allows differentiation between the prognosis of type 1 and type 2 diabetes (Kim et al., 2016).